End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
17.85
CNY
|
+0.22%
|
|
+0.34%
|
+6.69%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
47,781
|
47,493
|
49,277
|
60,072
|
56,107
|
59,329
|
-
|
-
|
Enterprise Value (EV)
1 |
63,090
|
55,488
|
57,141
|
69,931
|
69,900
|
77,745
|
78,742
|
69,421
|
P/E ratio
|
12.8
x
|
12.2
x
|
11.1
x
|
11.1
x
|
16.4
x
|
12.4
x
|
10.9
x
|
9.5
x
|
Yield
|
2.4%
|
2.5%
|
2.11%
|
3.42%
|
2.45%
|
3.35%
|
3.77%
|
4.11%
|
Capitalization / Revenue
|
0.26
x
|
0.25
x
|
0.23
x
|
0.26
x
|
0.22
x
|
0.21
x
|
0.19
x
|
0.17
x
|
EV / Revenue
|
0.34
x
|
0.29
x
|
0.26
x
|
0.3
x
|
0.27
x
|
0.27
x
|
0.25
x
|
0.2
x
|
EV / EBITDA
|
8.22
x
|
5.85
x
|
5.53
x
|
6.24
x
|
7.47
x
|
7.09
x
|
6.03
x
|
4.84
x
|
EV / FCF
|
19.3
x
|
13.2
x
|
60.6
x
|
31.5
x
|
28.6
x
|
40.4
x
|
121
x
|
20.2
x
|
FCF Yield
|
5.18%
|
7.6%
|
1.65%
|
3.17%
|
3.49%
|
2.48%
|
0.83%
|
4.96%
|
Price to Book
|
1.25
x
|
1.2
x
|
1.14
x
|
0.98
x
|
0.9
x
|
0.92
x
|
0.86
x
|
0.82
x
|
Nbr of stocks (in thousands)
|
2,842,089
|
2,842,089
|
2,842,089
|
3,696,414
|
3,703,301
|
3,703,301
|
-
|
-
|
Reference price
2 |
18.37
|
19.20
|
19.87
|
17.83
|
16.73
|
17.85
|
17.85
|
17.85
|
Announcement Date
|
3/27/20
|
3/26/21
|
3/29/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
186,566
|
191,909
|
215,824
|
231,981
|
260,295
|
288,274
|
317,121
|
348,524
|
EBITDA
1 |
7,672
|
9,483
|
10,324
|
11,216
|
9,360
|
10,959
|
13,063
|
14,345
|
EBIT
1 |
6,214
|
7,184
|
8,205
|
9,015
|
7,667
|
9,256
|
11,514
|
12,844
|
Operating Margin
|
3.33%
|
3.74%
|
3.8%
|
3.89%
|
2.95%
|
3.21%
|
3.63%
|
3.69%
|
Earnings before Tax (EBT)
1 |
6,262
|
7,175
|
8,144
|
8,808
|
7,054
|
8,605
|
10,056
|
11,287
|
Net income
1 |
4,081
|
4,496
|
5,093
|
5,617
|
3,768
|
5,075
|
5,852
|
6,466
|
Net margin
|
2.19%
|
2.34%
|
2.36%
|
2.42%
|
1.45%
|
1.76%
|
1.85%
|
1.86%
|
EPS
2 |
1.440
|
1.580
|
1.790
|
1.610
|
1.020
|
1.437
|
1.642
|
1.879
|
Free Cash Flow
1 |
3,269
|
4,219
|
942.6
|
2,219
|
2,440
|
1,925
|
650.1
|
3,442
|
FCF margin
|
1.75%
|
2.2%
|
0.44%
|
0.96%
|
0.94%
|
0.67%
|
0.2%
|
0.99%
|
FCF Conversion (EBITDA)
|
42.61%
|
44.49%
|
9.13%
|
19.78%
|
26.07%
|
17.57%
|
4.98%
|
23.99%
|
FCF Conversion (Net income)
|
80.11%
|
93.83%
|
18.51%
|
39.5%
|
64.76%
|
37.93%
|
11.11%
|
53.23%
|
Dividend per Share
2 |
0.4400
|
0.4800
|
0.4200
|
0.6100
|
0.4100
|
0.5977
|
0.6735
|
0.7329
|
Announcement Date
|
3/27/20
|
3/26/21
|
3/29/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
55,735
|
54,852
|
-
|
54,809
|
62,904
|
57,369
|
66,226
|
66,366
|
64,916
|
62,787
|
70,153
|
72,069
|
75,528
|
74,375
|
63,666
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
10,925
|
8,320
|
-7,752
|
-534.3
|
2,498
|
EBIT
1 |
1,571
|
1,404
|
-
|
3,804
|
1,822
|
1,393
|
2,666
|
1,893
|
1,998
|
1,489
|
2,415
|
7,894
|
-8,177
|
-960.1
|
2,046
|
Operating Margin
|
2.82%
|
2.56%
|
-
|
6.94%
|
2.9%
|
2.43%
|
4.02%
|
2.85%
|
3.08%
|
2.37%
|
3.44%
|
10.95%
|
-10.83%
|
-1.29%
|
3.21%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,417
|
7,745
|
-8,373
|
-1,136
|
1,891
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,542
|
6,933
|
-9,432
|
-2,089
|
1,115
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2.2%
|
9.62%
|
-12.49%
|
-2.81%
|
1.75%
|
EPS
2 |
0.3200
|
0.2100
|
0.4400
|
0.6900
|
0.3000
|
0.1600
|
0.4100
|
0.3000
|
0.3200
|
-0.0100
|
0.4200
|
1.131
|
-1.133
|
-0.0820
|
0.3656
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.5522
|
-
|
-
|
-
|
Announcement Date
|
10/29/21
|
3/29/22
|
4/28/22
|
8/29/22
|
10/27/22
|
3/30/23
|
4/26/23
|
8/29/23
|
10/27/23
|
3/28/24
|
4/26/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,309
|
528
|
7,864
|
9,858
|
13,792
|
13,267
|
19,413
|
10,092
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.995
x
|
0.0568
x
|
0.7617
x
|
0.879
x
|
1.474
x
|
1.211
x
|
1.486
x
|
0.7035
x
|
Free Cash Flow
1 |
3,269
|
3,835
|
943
|
2,219
|
2,440
|
1,925
|
650
|
3,442
|
ROE (net income / shareholders' equity)
|
10.1%
|
10.3%
|
10.8%
|
9.11%
|
5.56%
|
7.22%
|
8.41%
|
8.49%
|
ROA (Net income/ Total Assets)
|
3.09%
|
3.14%
|
3.26%
|
3.11%
|
1.84%
|
2.81%
|
2.87%
|
2.95%
|
Assets
1 |
131,943
|
143,105
|
156,308
|
180,784
|
205,005
|
180,693
|
203,674
|
218,818
|
Book Value Per Share
2 |
14.70
|
16.00
|
17.40
|
18.10
|
18.50
|
19.50
|
20.70
|
21.80
|
Cash Flow per Share
2 |
2.120
|
2.410
|
1.780
|
1.280
|
1.410
|
1.170
|
2.930
|
2.220
|
Capex
1 |
2,753
|
3,010
|
4,119
|
2,525
|
2,791
|
3,018
|
3,021
|
3,113
|
Capex / Sales
|
1.48%
|
1.57%
|
1.91%
|
1.09%
|
1.07%
|
1.05%
|
0.95%
|
0.89%
|
Announcement Date
|
3/27/20
|
3/26/21
|
3/29/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
17.85
CNY Average target price
20.78
CNY Spread / Average Target +16.42% Consensus |
1st Jan change
|
Capi.
|
---|
| +6.69% | 8.19B | | +17.35% | 71.39B | | +2.39% | 25.1B | | +5.38% | 8.59B | | -20.96% | 7.91B | | +0.49% | 4.54B | | +17.12% | 4.31B | | -3.38% | 3.93B | | -2.61% | 3.86B | | +22.08% | 3.64B |
Pharmaceuticals Wholesale
|